Professor Paul Wood
Professor Paul Wood AO FTSE Director
Professor Wood AO led R&D teams from CSIRO, CSL and Pfizer (now Zoetis) and was Deputy-Director of the Vaccine Technology CRC. He brought several innovations to market, receiving recognition for inventing a new diagnostic test for Tuberculosis. Paul was Chair of GALVmed and on the Board of Dairy Australia and Nexvet Biopharma and an Adjunct Professor at Monash University. Paul is the Chair of an Insect farming start-up Viridian Renewable Technology and on the scientific advisor group for the Global Methane Hub and a former advisor to the BMGF livestock program.

Fellow status Elected 2015 Division VIC
Fellowship Affiliations P&R Wood Partners Classification Industry Sector Expertise 212 - Biotechnology, 411 - Research and development

Dr Wood is recognised internationally as a scientist and commercial R&D leader particularly for his unique discoveries for the diagnosis of human and bovine tuberculosis. As a researcher at CSIRO he was responsible for the discovery of a novel patented technology for diagnosing TB in beef cattle. He moved to CSL to head up its veterinary products R&D. The unique tuberculous technology was developed at CSL for human diagnosis and was commercialised internationally by CSL and subsequently Cellestis. Dr Wood spent four years as Executive Director of Pfizer Animal Health in the US and shared a Clunies Ross Award in 2013.